Dihydromyricetin
Evidence status
Limited evidence to recommend for any consumer outcome yet.
1 papers · 0 claims · 2 outcomes scored
Risk profile
Adverse events and known drug interactions
Safety events
elevation of alanine aminotransferase (ALT)
elevation of aspartate aminotransferase (AST)
elevation of blood urea nitrogen (BUN)
increased creatinine
increased mean corpuscular hemoglobin concentration (MCHC)
no observed adverse effect (NOAEL > 1998 mg/kg/day)
Drug interactions
Adriamycin moderate additive
Drug:Acetaminophen moderate decreases effect
Methotrexate moderate decreases effect
Drug:Acetaminophen minor decreases effect
Fluconazole minor unknown
Co-studied with
Supplements that share evidence with dihydromyricetin
Sources
Generated August 14, 2026